Clinical Trial Update: A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating STEMVAC, a multiple antigen vaccine, for Stage IV non-small cell lung cancer. The study is active not recruiting and results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• STEMVAC

Snippet

Sponsor: University of Washington | Conditions: Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-04-03